Ural Triazavirin has finally been released. This antiviral drug developed by Sverdlovsk scientists has come pharmacies today. This is such a long-awaited event that the Ural medicine has been sold out briskly.

Now, Triazavirin is no more a powder in a test-tube but a certified drug. Scientists have been waiting for this moment for almost 30 years. Oleg Chupakhin, a co-developer and Scientific Director of the Institute of Organic Synthesis of the Ural Branch of the Russian Academy of Sciences, bought five packages at once as a souvenir: “This is a huge victory of many people who have been working on it. I think that our brainchild is by far the world's best drug for influenza by now."

This medicine does not just eliminate symptoms but rather affects directly the core, the infectious agent. In contrast to Western analogues, no virus is available in a patient's blood already on the second day of use. Additionally, Triazavirin's price is almost twice as low as compared to foreign drugs. The price of the box is 805 roubles.

Now, Triazavirin is produced at the Novouralsk plant. There, new laboratories were built for this end. As domestic raw materials are used, the price of Triazavirin, according to the developers, will remain stable. A foreign analogue depends on the USD exchange rate. By the way, Alexander Petrov, the project supervisor, has been taking the Ural drug for several years. Alexander Petrov, State Duma deputy, member of the Health Committee: “The leader who does not test a medicine on himself is bad. Since I work with a large number of people, I have to take this drug for prevention reasons. I can tell you that, over the past year and a half, I have not had flu; this is already a kind of ads, sorry.”

In 2015, Triazavirin will be sold only as a prescribed drug; later, it will be available for free sale. Sverdlovsk doctors are aware of the new drug. Lyudmila Shubina, a resident of Yekaterinburg: “We are aware of all new products.” The Sverdlovsk researchers are confident that Triazavirin's potential is to be revealed yet. It has been proven that it helps with 15 types of flu and tick-borne encephalitis. However, the developers claim that Triazavirin can save the world even from Ebola.